HOME >> MEDICINE >> NEWS
Stroke news tips for Friday, Feb. 8, 2002

., Michigan State University, (517) 353-8623; e-mail: reevesm@msu.edu.

5:30 p.m. #P164 Chiropractic manipulation may be underestimated as cause of stroke Stroke as a result of chiropractic manipulation may be underreported, especially in young women, according to the largest known prospective study of arterial trauma and stroke. In this ongoing study, Canadian researchers examined 98 cases in which external trauma ranging from trivial to severe was identified as the trigger of ischemic strokes, the type of strokes caused by the formation of blood clots in arteries supplying the brain with blood. Chiropractic-style neck manipulation was the apparent cause in 39 percent of cases (38 cases). Of the 98 cases, there were 30 vertebral and 8 carotid dissections. More occurred in women (36) than in men (12). Sixteen percent of individuals studied had a congenital disorder such as Marfans Syndrome, fibro-muscular dysplasia (FMD) or Ehles-Danlos Type IV Syndrome. These conditions may make individuals more vulnerable to trauma-related injuries to their fragile arteries. Epidemiological data from Canadian statistics indicate the incidence of ischemic strokes in people under age 45 is about 750 a year. The researchers say that their data indicates that 20 percent are due to neck manipulation, so there may be a gross underreporting of chiropractic manipulation as a cause of stroke.

Dr. Beletsky can be reached at (416) 480-4287 and by e-mail at vados@istar.ca.

5:30 p.m. #P172 Hyperglycemia linked to poor stroke prognosis. Animal and human studies indicate that high blood sugar (hyperglycemia) during stroke is associated with larger areas of brain-damaged tissue and a poor prognosis. In this study, researchers analyzed the outcomes of patients who had hyperglycemia before receiving thrombolysis (clot-busting). Of 119 patients treated with thrombolytics between December 19
'"/>

Contact: Carole Bullock
210-582-7159
American Heart Association
8-Feb-2002


Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Stroke awareness low among women, especially minorities
2. Stroke warning signs often occur hours or days before attack
3. Canadian neurologist wins highest award as American Stroke Association honors five
4. Stroke patients receive better care when hospitals get with the guidelines
5. Strokes: Dental x-rays reveal more than cavities
6. Stroke treatment window stays open longer than thought, say Stanford researchers
7. Stroke news tips for Saturday, Feb. 7, 2004
8. Stroke news tips for Friday, Feb. 6, 2004
9. Stroke news tips for Thursday, Feb. 5, 2004
10. American Stroke Associations 29th International Stroke Conference
11. Stroke may increase risk of Alzheimer disease

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Stroke news tips for Friday Feb

(Date:10/22/2014)... October 22, 2014 Lintelus, Inc., an ... Vice President of Sales, will be speaking on the ... Technology Expo on October 28, at the Holiday Inn ... a booth as well as a Tech Demo at ... can create a more engaging event experience. , The ...
(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Maureen Salamon HealthDay Reporter ... undergoing in vitro fertilization (IVF) are only about half as ... assisted reproduction technique, new research indicates, and the racial disparity ... study, about 31 percent of white patients became pregnant after ... Analyzing more than 4,000 IVF cycles over two years to ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... to increased blood pressure, according to a new study. ... pressure for young adult women or for teenagers, according to ... or moderately, their risk of high blood pressure was cut ... in older adult men and women," said lead researcher Dr. ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... JOLLA, Calif. , Oct. 22, 2014 ... RGLS ), a biopharmaceutical company leading the ... microRNAs, today announced that it has demonstrated ... an ongoing clinical study evaluating RG-101, a ... the treatment of hepatitis C virus infection ...
(Date:10/20/2014)... , 20 de octubre de 2014  PneumRx, ... campo de la pulmonología intervencional, anunció hoy la ... casi 3 meses antes de lo programado. El Estudio ... de dispositivo de investigación (IDE) aprobada por la ... sistema de espiral de reducción de volumen pulmonar ...
(Date:10/20/2014)... 20, 2014  ResMed (NYSE: RMD ... Data Exchange program, a comprehensive suite of software ... and other health care providers. ... critical patient information. It integrates valuable sleep and ... patient management platforms with customers, in-house or third-party ...
Breaking Medicine Technology:A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8PneumRx concluye inscripción en prueba fundamental RENEW 2PneumRx concluye inscripción en prueba fundamental RENEW 3ResMed Launches ResMed Data Exchange 2
Cached News: